• Transcriptomes and enhancers of human CD4 + T follicular helper and non-Tfh T effector cells reveal cell typespecific differences.
Introduction
T follicular helper (Tfh) cells are a subset of CD4 + T helper (Th) lymphocytes that migrate into the B cell follicle and provide germinal center (GC) B cells with survival and differentiation signals essential for B cell selection with maturation into memory B cells and long-lived antibody-secreting plasma cells. [1] [2] [3] [4] [5] [6] [7] [8] Tfh cells also secrete cytokines that enable B cell isotype class switching appropriate to invading pathogens. [8] [9] [10] Tfh cells can be distinguished from other Th cells by down regulation of P-selectin glycoprotein ligand 1 (PSGL-1) required for their emigration from T cell zones of secondary lymphoid organs towards the B cell follicle, and by their sustained expression of the transcriptional repressor B-cell lymphoma 6 (BCL6), the C-X-C chemokine receptor type 5 (CXCR5) needed for their migration into the follicle, and the programmed cell death receptor (PD-1) necessary for proper B cell maturation therein in GCs. 11, 12 Although Tfh cells are essential for the GC response, much less is known about their origin, development and function compared to other CD4 Th cell subsets. 13 Tfh cells are abnormally regulated in several inherited and acquired diseases. 14, 15 Expansion of dysfunctional Tfh cells is a major contributor to systemic autoimmunity, including systemic lupus erythematosus (SLE, lupus), Sjogren's syndrome, and rheumatoid arthritis. 16, 17 Their malignant transformation results in the phenotype of angioimmunoblastic Tcell lymphoma (AITL), a subset of peripheral T-cell lymphoma (PTCL). [18] [19] [20] [21] [22] Tfh cells are thought to be the origin of subtypes of primary cutaneous T-cell lymphoma. 23, 24 A possible contributory role for Tfh cells in graft versus host disease also has been suggested. 25 Recent advances in genomic technologies have revolutionized our understanding of gene expression and gene regulation, and their relationship to mechanisms of human disease. 26 Detailed information on cellular transcriptomes obtained by RNA sequencing (RNA-seq) provides unbiased information on transcript composition and abundance, including detection of novel transcripts, novel isoforms, alternative splicing, and allele-specific expression. [27] [28] [29] Similarly, genomic strategies have allowed understanding of programs controlling cellular development and differentiation by providing insight into the regulatory DNA sequences that control or regulate these programs.
Enhancers are DNA regulatory sequences with numerous, complex roles in the control of gene expression, [30] [31] [32] [33] participating in cellular development, differentiation and cell fate determination. [34] [35] [36] [37] They assist in determining nuclear organization, 33 transcription initiation and the release of RNA polymerase II from promoter pausing, 38 transcriptional competence, 36 and insulator element activity. 39, 40 Noncoding RNAs have also been linked to enhancer function [41] [42] [43] [44] [45] [46] [47] and intergenic enhancers may act as alternate, tissue-specific promoters generating abundant, spliced, multiexonic poly(A) + RNAs. 48 Secondary enhancers synergize with primary enhancers to fine tune gene expression. 49, 50 Recent studies in three dimensional transcriptional space reveal that turning on and off enhancers during development correlates with promoter activity and that promoter-enhancer interactions are highly cell-type specific varying widely across the genome. [51] [52] [53] [54] Numerous studies characterizing enhancers in human lymphoid cells on a genome wide scale have been performed. [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] Despite their biologic relevance, data are not available for human primary Tfh cell enhancers, perhaps because of the difficulty in obtaining adequate samples for analysis. Obtaining sufficient numbers from mice is also 
Methods

Flow cytometry and cell sorting
To obtain primary human Tfh and Teff cells, human tonsils were cut into small sections and homogenized by crushing followed by straining through a 40μM nylon filter. CD4 + T lymphocytes were enriched using a negative selection biotin-based magnetic separation kit (EasySep; StemCell Technologies) prior to cell surface staining with the antibodies to: CD4 (clone RPA-T4), CD45RA (clone HI-100), TCRβ (clone IP26), PD-1 (clone EH12.1), CXCR5 (clone RF8B2), and PSGL-1 (clone KPL-1)(all from BD Biosciences). Staining of CXCR5 was performed at room temperature (25°C) with 1 hour incubation. Intracellular staining for Foxp3 was performed using Foxp3/Transcription Factor Staining Buffer Set™ (eBiosciences) following the manufacturer's protocol. Stained and rinsed cells were analyzed using an LSRII Multilaser Cytometer (BD Biosciences) or specific populations sorted using a FACSAria (BD Bioscience).
Cell selection and RNA analyses
RNA was isolated from lymphocytes and prepared for RNA-seq analyses as described. 67 Samples were sequenced on an Illumina HiSeq 2000 using 75bp-paired end reads. FASTQ format sequencing reads were aligned to the hg19 genome, NCBI Build 37, using TopHat Version 2.0.4 software with default parameters except minimum anchor length of 12. The EdgeR program was used to identify differences in expression of RefSeq transcripts. Filtering included transcripts with >1 tag/million reads in 3 or more samples. Quantitative real-time PCR was performed to confirm expression levels of RNA transcripts (Supplemental Table S1 ). Gene Set Enrichment Analysis (GSEA) was performed as described using default parameters except 10,000 permutations were performed. 68 
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as previously described. 69 Samples were immunoprecipitated with antibodies against monomethyl histone 3 lysine 4 (H3k4me1, Abcam ab8895), trimethyl histone 3 lysine 27 (Abcam ab6002), acetyl histone 3 lysine 27 (H3K27Ac, Abcam ab4729), and nonspecific rabbit IgG (sc-2091, Santa Cruz).
High throughput sequencing and data analyses
DNA processing and high throughput sequencing were performed as described. 67 Table S2 ). Immunoprecipitated DNA was analyzed by quantitative real-time PCR (iCycler, Bio-Rad) as described. 69 
Identification and analysis of biologically relevant SNPs
The locations of SNPs shown to demonstrate highly significant linkage to immune disorder-related traits (Supplemental Table S3 ) were obtained from the UCSC genome browser database and the catalog of published GenomeWide Association Studies (GWAS) compiled by the National Human Genome Research Institute (www.genome.gov/gwastudies). 75 Using BedTools software, enhancers were intersected with immune disorder-related SNPs and overlap identified.
Reporter gene assays
Candidate enhancer regions were amplified using primers flanking the boundaries of called peaks (Supplemental Table S4 ) and cloned upstream of an SV40 promoter-firefly luciferase reporter cassette in the pGL2Promoter plasmid.
Transfections were performed as described. 76 10 7 Jurkat cells (ATCC, TIB-152) were transfected by electroporation with a single pulse of 300V at 950μF with 15μg of test plasmid and 0.3µg of pRL-TK, a reporter plasmid expressing Renilla luciferase driven by the Herpes simplex virus thymidine kinase (HSV-TK) promoter (Promega) as described. 77 Two days after transfection, cell extracts were analyzed using the Dual-Luciferase assay according to manufacturer's instructions (Promega).
Data access
The raw data files generated by the RNA seq and ChIP-seq analyses have been submitted to Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/, Reference series GSE58597). Figure   1B ). Thus, the small numbers of Tfr cells found in the Tfh cell sorting gate should not significantly bias our transcriptome and genomic analyses.
RNA was isolated and RNA-seq performed to obtain the transcriptome of Tfh, Teff, and naïve T cells.
Multidimensional scaling was performed on expressed genes (>1cpm in 3 or more samples) to assess sample relatedness.
Samples from each cell type clustered together ( Figure 2A ), indicating that samples from each cell type were closely related and distinct from the other cell types. Quantitative real-time PCR validated expression levels of representative mRNA transcripts detected by RNA-seq (Supplemental Table S5 ). Overall, 11,839, 12,007, and 12,202 transcripts were expressed in Tfh, Teff, and naïve T cell RNA, respectively, with 11,307 expressed in all 3 cell types (Supplemental Figure   S1 ).
EdgeR, a Bioconductor software package for examining differential expression of replicated count data, identified the differentially expressed transcripts among the three cell types ( Figure 2B ). These genes were sorted by absolute differences (fold change) in their expression (Supplemental Table S6 ) and heat maps displaying patterns of differentially expressed genes prepared ( Figure 2C and Supplemental Figure S2 
Gene Set Enrichment Analysis (GSEA). Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of peripheral
T-cell lymphoma (PTCL) with a molecular signature indicating origin from Tfh cells (see below). 20, [78] [79] [80] [81] [82] [83] To better understand Tfh cell gene expression in AITL, we performed GSEA using a gene set containing genes up regulated in Tfh
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From cells compared to Teff cells. We compared 37 AITL samples from the dataset GSE19069, 78 to the 60 non-AITL samples, primarily containing other malignancies of T-cell origin, in the data set (Supplemental Figure S3) . The normalized enrichment score, which reflects the degree to which a gene set is overrepresented at the top or bottom of a ranked list of Table S7 ). Figure 3A -C). Heat maps generated by ranked plots averaged across rows of HeK4me1, H3K27Ac, and/or H3K27me3 peaks revealed patterns of distinct chromatin architecture characteristic of the enhancer classes ( Figure 3D ).
Identification of multiple classes of Tfh and
The human genome was portioned into seven bins relative to RefSeq genes corresponding to exons, introns, promoters, distal (-1 to -50kb), downstream (+1 to +50kb), and intergenic regions. Sites of specific histone modifications and enhancer class were assigned to these bins and percentages calculated ( Figure 4A ). In Tfh cells, poised enhancers were less frequently found in introns, but were found more frequently in the 5' and 3' distal regions of associated genes.
Similar localization of poised enhancers was observed in Teff cells ( Figure 4B ).
Expression and function of genes associated with enhancer classes in Tfh and Teff cells. Typically, cell and
tissue-type specific enhancers act over distances of tens to hundreds of kilobases. 86 Thus, bona fide Tfh and Teff cell enhancers are expected to be enriched in the genomic vicinity of genes that are expressed and functional in their respective cells. [87] [88] [89] To determine whether Tfh and Teff cell enhancers are localized in this manner, gene expression in We also examined whether enhancers were enriched near genes with known Tfh and Teff cell function. We performed a statistical enrichment analysis of functional gene annotations associated with each type of enhancer class. 74 Tfh cell active and intermediate enhancers were associated with genes linked to immune cell-related biological functions whereas poised enhancers were associated with genes involved in cellular development and differentiation (Supplemental Figure S5A) . The top enriched phenotypes linked to genes associated with Tfh cell active enhancers were immune and lymphocyte-related phenotypes (Table 2) Similar to results previously observed, 85 only poised enhancers showed strong conservation in both cell types (Supplemental Figure S6) .
Motif enrichment. The Homer program was utilized to identify over-represented DNA/transcription factor motifs at sites of candidate enhancers. The top over-represented motifs at sites of active enhancers in Tfh cells were ETS, ZIC2, TLX, and MEF2C with over-representation of ETS, RUNX1, and DCE in Teff cells (Supplemental Figure S7) .
Enhancer classes and biologically relevant single nucleotide polymorphisms.
We explored whether SNPs associated with biologically relevant immune cell traits and with immune cell traits were enriched in Tfh cell enhancers.
We utilized the set of non-coding SNPs from the GWAS catalog of the NHGRI (www.genome.gov/gwastudies) 75 and we collected a data set of immune-associated non-coding SNPs. (See Methods; there are 1514 SNPs associated with these terms from the GWAS catalog.) Currently, the functional significance of the overwhelming majority of these SNPs is unknown. SNP locations were compared to the locations of Tfh cell enhancers. For active Tfh enhancers, there was association with 321 SNPs in the GWAS catalog with 86 (5.7%) related to immune cell traits (Supplemental Table S8 ).
For intermediate Tfh enhancers, there was association of 197 SNPs in the total GWAS catalogue with 38 (2.5%) related to immune cell traits. For poised Tfh enhancers, there were no SNPs linked to immune cell traits (Supplemental Table S8 ).
Examples of immune disease-associated SNPs with Tfh cell active enhancers are shown in Supplemental Figure S8 .
A subset of enhancers, called super enhancers or stretch enhancers, important for regulating genes critical for celltype specific identify, have been described. 90, 91 Super enhancers span large regions of chromatin, have domains of transcription factor binding sites and are marked by significant amounts of H3K4me1 and H3K27Ac modification. We identified super enhancers in Tfh cell chromatin as described by finding regions with the highest levels of clustered, K27 acetylated chromatin ( Figure 5 ). 90, 92 In some cell types, disease-associated SNPs are enriched in super enhancers of relevant cell types, suggesting that altered expression of key cell identity genes may contribute to disease phenotype. 91, 92 For Tfh cell super enhancers, there was association with 893 SNPs in the total GWAS catalog with 119 SNPs (13%) linked to immune cell traits (Supplemental Table S9 ). Relevant SNPs were found in super enhancers near the MAF, IRF4, and BATF gene loci ( Figure 5 ). For super enhancer-associated SNPs, the majority were associated with rheumatoid Tfh cell type specific enhancers. To assess the cell-type specificity of the enhancers identified, we compared Tfh enhancers marked by non-promoter associated peaks of H3K4 monomethylation to enhancers in 61 different cell types.
This identified 1660 enhancers that were present in Tfh cell chromatin but were not present in the other cell types. To further refine cell type specificity, we next compared enhancers marked by non-promoter associated peaks of H3K4 monomethylation in Tfh cells to enhancers in 13 hematopoietic cell types, primarily lymphoid cells. We identified 7166
nonpromoter-associated H3K4me1 peaks in Tfh cell chromatin not present in the 13 other cell types, with 9475 not identified in the 10 lymphoid cell types. Jaccard coefficient clustering revealed that hematopoietic cell enhancers clustered distinctly from human embryonic stem cell enhancers (for comparison) and lymphoid cell enhancers clustered distinctly from other hematopoietic cell enhancers (not shown).
To identify enhancers potentially contributing to differential gene regulation in Tfh and Teff cells, we compared levels of H3K27 acetylation at non-promoter peaks of H3K4me1 in Tfh and Teff cell chromatin, as relative amounts of acetylation have been correlated with enhancer strength or levels of gene expression. 93 There were 1281 differentially acetylated enhancers between the 2 cell types ( Figures 6A and 6B ). We then determined if the genes nearest these differentially acetylated enhancers were also differentially expressed in the associated cell type. There were 43 differentially marked enhancers associated with differentially expressed genes (Table 3) Table S10 ), cell lysates collected after 2 days, and luciferase activity analyzed. All 7 Tfh cell-specific enhancers directed statistically significant (p<0.05) reporter gene activity between 2 and 3.5 times over activity of control (Supplemental Figure S9 ).
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From
Discussion
Tfh cells are necessary for B cell maturation into memory and long-lived plasma cells in GCs of B cell follicles. 94 They provide signals to cognate B cells via CD40 ligand, programmed cell death 1 (PD-1), and cytokines, including IL-21 and IL-4, promoting B cell proliferation and affinity maturation within the GC. [95] [96] [97] [98] [99] Tfh cell development requires the transcription factors Achaete-scute complex homolog 2 (ASCL2) and BCL6, leading to expression of transcripts important for their function, while repressing activation of genes, among them Blimp1 (PRDM1), critical for development of other T helper subsets. 5, 8, 10 ASCL2 and BCL6 up regulation also promotes expression of the chemokine receptor CXCR5 necessary for Tfh cell entry into the B cell follicle following a gradient of its ligand CXCL13. 11, 12 Genes encoding these proteins were all highly expressed in the Tfh cells we isolated from tonsils.
Our integrative analyses also revealed that several of these genes were associated with Tfh-cell type specific enhancers, including PDCD1, CXCR5, and BCL6, suggesting that these cis-elements are critical for Tfh cell identify and lineages and highlighting the plasticity of Tfh cells. 112 Further refining these varying cellular populations, e.g. by using single cell transcriptome analyses, will provide insight into T effector cell development, differentiation, and function. 113 Angioimmunoblastic T-cell lymphoma is an uncommon subtype of peripheral T-cell lymphoma with a poor prognosis. 114 Initial studies revealed a pan T-cell phenotype with expression of Tfh markers including CD10, CXCL13, 20 Combining detailed transcriptome information provided by RNA-seq with genome wide mutation analyses will allow further refinement of these lymphoma subtypes, allowing better assignment of disease diagnosis and prognosis, as well as revealing novel targets for therapeutic strategies.
Genome wide association studies (GWAS) have identified many single nucleotide polymorphisms (SNPs) enriched in patients with autoimmune diseases, leading to the identification of many disease-associated loci. 121, 122 Frequently, specific SNPs are found in more than one autoimmune disorder, in line with the observation that some patients suffer from more than one such disorder, with certain polymorphisms likely contributing to common causality. 123 Most variants identified in GWAS studies are outside coding regions, 124 and are enriched for regulatory and transcriptionally functional SNPs. 125 Because expansion of dysfunctional Tfh cells is a major contributor to systemic autoimmunity, we examined the relationship between Tfh cell enhancers and super enhancers and SNPs identified in GWAS. We found many SNPs linked to autoimmune diseases by GWAS in Tfh cell enhancers, particularly multiple sclerosis, rheumatoid arthritis, and type I diabetes, with several linked to multiple such illnesses, with even more significant enrichment in Tfh cell super enhancers. The challenge now is to translate the linkage of autoimmune SNPs and Tfh cell enhancers and super enhancers to a better understanding of Tfh cell development and differentiation and to determine the functional significance of variants associated with quantitative traits linked to autoimmune disease.
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